The Pursuit of Hepatitis C EliminationHow the Pharmacist Can Make a Difference
Attitudes and potential barriers towards hepatitis C treatment in patients with and without HIV coinfection.
Allyn PR, et al. Int J STD AIDS. 2018;29(4):334-340.
Pharmacist engagement within a hepatitis C ambulatory care clinic in the era of a treatment revolution.
Gauthier TP, et al. J Am Pharm Assoc (2003). 2016;56(6):670-676.
A regional analysis of hepatitis C virus collaborative care with pharmacists in Indian health service facilities.
Geiger R, et al. J Prim Care Community Health. 2018;9:1-5.
Medical and behavioral approaches to engage people who inject drugs into care for hepatitis C virus infection.
Gonzalez SA, et al. Addict Disord Their Treat. 2017;16(2 suppl 1):S1-S23.
Pharmacist-initiated hepatitis C virus screening in a community pharmacy to increase awareness and link to care at the medical center.
Isho NY, et al. J Am Pharm Assoc (2003). 2017;57(suppl 3):S259-S264.
Kugelman M, et al. Gastroenterol Hepatol. 2017;13(2):98-104.
Optimizing hepatitis C virus treatment through pharmacist interventions: identification and management of drug-drug interactions.
Langness JA, et al. World J Gastroenterol. 2017;23(9):1618-1626.
Verma S, Leeman D; London Joint Working Group. Published May 2018.
Implementation of a hepatitis C collaborative drug therapy management service in an HIV ambulatory care clinic.
Sorbera M, et al. Innov Pharm. 2018;9(1).
Sullivan K, et al. P T. 2018;43(12):764-768.
American Liver Foundation
The American Liver Foundation’s Hepatitis C Information Center website is a dedicated online information and resource center created in support of individuals impacted by HCV infection.
HepatitisC.net is a website for people living with HCV that offers education, tools, and resources. Articles are written by people living with or cured of HCV, patient advocates, and medical providers.
Centers for Disease Control and Prevention (CDC; last reviewed November 2018)
The CDC is a division within the US Department of Health and Human Services (DHHS), the principal agency for protecting the health of all Americans. This patient-directed website addresses basics across the HCV clinical continuum.
Part 1: The Pharmacist's Role in HCV Testing and Counseling—Reaching Patients With the Greatest Need
Part 2: Understanding the Landscape of Current HCV Treatment
The PCPs Role in Preventing HIV
What Do You Know About PrEP?
Optimizing Use of Clinical Evidence & Pharmacoeconomic Models in Managed Care
Advances in the Diagnosis and Treatment of Nonalcoholic Steatohepatitis
What Do You Know About PrEP?
Got it? Treat it!
The Critical Role of the Community Pharmacist
Bringing Local Communities Together to Eliminate Coinfection Through Knowledge and Partnerships.
Volume 1: Rapid ART Initiation: A New Addition to the HIV-Care Tool Box
The Emerging Role of the Diabetologist
Key Issues Impacting OB/GYN Practice
An Interactive Experience Highlighting Recent Clinical Advances
Hot Topics in HBV, HCV, and NASH
Emerging Concepts in Patient Management
Building Your Understanding to Combat a Growing Problem
Volume II: Expanding Evidence for the Role of Rapid ART Initiation in HIV Practice
Why It Matters in OB/GYN Practice Today
A Treater’s Guide to Optimizing Care in the Aging Patient with Comorbidities
HIV Can Be Prevented— Are You Doing Your Part?
Rapid Start ART — A New Model for HIV Care
Understanding the Growing Syndemic — Opioids, HCV, and HIV
Appraising the Therapeutic Armamentarium in Moderate and Severe Disease
A PrEP Primer
The PCP’s Role in HCV Elimination
What the Pharmacist Needs to Know about PrEP
The Rapid ART Standard of Care: From Evidence to Healthcare Equity
Maximizing Your Role to Impact Patient Outcomes
Building Bridges to Reach People Who Inject Drugs With the Goal to Eliminate HCV
Benefits, Barriers, & Best Practices in an Advancing Field
Practical Solutions Across the Spectrum of Care
A PEP/PrEP Training Guide for Pharmacists
An Interactive Learning Experience
A Focus on Clinical Evidence and Guideline Recommendations
A Critical Step Toward HCV Elimination
Considering the Patient, the Provider, and the Science
A Multidisciplinary Online Mini-Curriculum
Volume 1: A Guided Tour of the Evidence Driving Selection of First-line Advanced Therapies in Moderate to Severe IBD
Debates and Discussions about Monoclonal Antibody Therapies
An Update on Monoclonal Antibody Therapies